Kuniaki Kaga
Direktor/Vorstandsmitglied bei NXERA PHARMA CO., LTD.
Aktive Positionen von Kuniaki Kaga
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NXERA PHARMA CO., LTD. | Direktor/Vorstandsmitglied | 22.06.2018 | - |
| Independent Dir/Board Member | 22.06.2018 | - | |
| SUSMED,INC. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
| Independent Dir/Board Member | 01.01.2021 | - |
Karriereverlauf von Kuniaki Kaga
Ehemalige bekannte Positionen von Kuniaki Kaga
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
| Präsident | 01.02.2015 | - | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Corporate Officer/Principal | 01.10.2005 | - |
Mitsubishi Chemical Corp. (Old)
 Mitsubishi Chemical Corp. (Old) Chemicals: SpecialtyProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of pharmaceutical intermediates and ingredients. It develops, produces, and sells performance products, health care products, industrial materials, and other chemicals. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 01.04.1975 | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Comptroller/Controller/Auditor | 14.07.2011 | 08.02.2012 |
| Direktor/Vorstandsmitglied | 01.06.2010 | - | |
| Compliance Officer | 01.06.2010 | - | |
| Geschäftsführer | 15.07.2011 | 08.02.2012 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.06.2010 | - | |
| Corporate Officer/Principal | 20.09.2010 | 14.07.2011 |
Ausbildung von Kuniaki Kaga
| University of Tokyo | Undergraduate Degree |
Statistik
International
| Japan | 8 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 2 |
Sektoral
| Health Technology | 4 |
| Process Industries | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| NXERA PHARMA CO., LTD. | Health Technology |
| SUSMED,INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Mitsubishi Chemical Corp. (Old)
Mitsubishi Chemical Corp. (Old) Chemicals: SpecialtyProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of pharmaceutical intermediates and ingredients. It develops, produces, and sells performance products, health care products, industrial materials, and other chemicals. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Process Industries |
The Kaiteki Institute, Inc.
The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Commercial Services |
- Börse
- Insiders
- Kuniaki Kaga
- Erfahrung
